Health and Healthcare
Teva Earnings and Guidance Offer No Immediate Shareholder Solutions
Published:
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) remains stuck after its earnings report. The generic and branded pharmaceutical drug maker turned in higher earnings that only met expectations. The company claims to be on track to reach its financial goals for the year, as the U.S. generics business continues to recover with a positive trend. It was also noted that the global branded division experienced strong growth, and that, despite the woes of Europe, the European generics business showed solid sequential growth from the first quarter, even if it was down from a year ago.
Teva reported earnings of $1.28 per share, versus $1.10 a year ago, on a 19% gain in sales to $5.0 billion. Thomson Reuters had estimates of $1.28 per share but revenue estimates were $5.08 billion. The company reaffirmed its 2012 targets of $20 billion to $21 billion with earnings (ex-items) of $5.30 to $5.40 per share.
U.S. sales were up 28% to $2.5 billion after launching new generics and branded products, while European sales were effectively unchanged at $1.5 billion.
Rather than looking at individual drug franchise sales, the reaction pretty much sums it up. The reaction in New York has shares down 1.5% at $40.25. The consensus analyst target was $50.50 before the effects of this earnings report came out. Shares were down only about 1% in Tel Aviv on last look.
JON C. OGG
Let’s face it: If your money is just sitting in a checking account, you’re losing value every single day. With most checking accounts offering little to no interest, the cash you worked so hard to save is gradually being eroded by inflation.
However, by moving that money into a high-yield savings account, you can put your cash to work, growing steadily with little to no effort on your part. In just a few clicks, you can set up a high-yield savings account and start earning interest immediately.
There are plenty of reputable banks and online platforms that offer competitive rates, and many of them come with zero fees and no minimum balance requirements. Click here to see if you’re earning the best possible rate on your money!
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.